Asia Pacific Anatomy Pathology Market By Products (instruments And Accessories), By Application (lymphoma, Breast, Lung, Colorectal, Cervical And Prostate), By End-user (diagnostic Lab, Hospitals, And Physicians' Office Lab), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Anatomy Pathology Market By Products (instruments And Accessories), By Application (lymphoma, Breast, Lung, Colorectal, Cervical And Prostate), By End-user (diagnostic Lab, Hospitals, And Physicians' Office Lab), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 3340 | Pages: 141 | September 2017 | Region: Asia Pacific


The Asia Pacific Anatomy Pathology Market was worth USD 2.59 billion in 2016 and is estimated to be growing at a CAGR of 7.92%, to reach USD 3.79 billion by 2021. The market is displaying obvious potential in the said determining period. Anatomy Pathology is the branch of medicine that deals with the diagnosis of diseases based on the various levels of examinations of organs and tissues.

Anatomy Pathology features the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. The data generated by Anatomy Pathology is further analyzed and is used by doctors for a better health management. Anatomy Pathology is basically one of the branches of the pathology stream, other being the Clinical Pathology.

With the enormous number of ongoing developments and innovations in the healthcare, rising spending capabilities and increasing awareness of the people in this region, there has also been a rise in the market. People have also become prone to more and more harmful diseases as the time has changed because of increasing adaptability of micro-organisms against various medications. This market is facing challenges mainly competing with the Physician Groups, like specialty physicians merging or adding ancillary services and large commercial labs. There is a constant significant reimbursement pressure. Awareness is increasing in this region about diseases at a very fast rate, still, overall awareness of the people is very less. These factors may act as growth hurdles for the Anatomy Pathology Market in this region.

The Asia Pacific Anatomy Pathology Market is broadly categorized by products, by application, and by end-user. Based on products, the market is segmented into instruments and accessories. On the basis of application, it has been categorized as lymphoma, breast, lung, colorectal, cervical and prostate. On the basis of end-user, the market has been classified into Hospitals, Diagnostics lab, and physicians’ office lab.

The Asia-Pacific region is geographically segmented into India, South Korea, China, Japan and Australia. Asia Pacific is one of the most lucrative markets for the growth of Anatomy Pathology market and is projected to grow the highest during the forecast period. Factors such as growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region.

The Asia Pacific Anatomy Pathology Market in this region is highly monopolized in this region. Some of the major companies dominating the market in this region are Sakura Finetechnical Co., Ltd. (Japan), MetroPolis (India) and IBISWorld’s Pathology Services (Australia).

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Instruments                           

                                5.1.3 Accessories                             

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

                5.2 End-User                                     

                                5.2.1 Introduction                           

                                5.2.2 Diagnostics Lab                      

                                5.2.3 Hospitals                  

                                5.2.4 Physicians' Office Lab                         

                                5.2.5 Y-o-Y Growth Analysis, By End-User                            

                                5.2.6 Market Attractiveness Analysis, By Type                   

                                5.2.7 Market Share Analysis, By End-User                            

                5.3 Application                                 

                                5.3.1 Introduction                           

                                5.3.2 Lymphoma                              

                                5.3.3 Breast                       

                                5.3.4 Lung                           

                                5.3.5 Cervical                     

                                5.3.6 Colorectal                

                                5.3.7 Prostate                   

                                5.3.8 Y-o-Y Growth Analysis, By Application                         

                                5.3.9  Market Attractiveness Analysis, By Application                      

                                5.3.10  Market Share Analysis, By Application                     

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Type  End-User

                                                6.1.3.4 By Application    

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Type  End-User

                                                6.1.4.4 By Application    

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Type  End-User

                                                6.1.5.4 By Application    

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 F. Hoffmann-La Roche AG                                    

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 NeoGenomics Laboratories Inc.                                        

                8.3 Laboratory Corporation of America Holdings                                               

                8.4 Thermo Fisher Scientific                                        

                8.5 Quest Diagnostics Incorporated                                        

                8.6 Agilent Technologies                                              

                8.7 Danaher Corporation                                             

                8.8 Sakura Finetechnical Co. Ltd.                                              

                8.9 Metropolis                                  

                8.10 IBISWorld’s Pathology Services                                       

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  2. Asia-Pacific Blood Glucose Monitoring Market By Region, From 2016-2021 ( USD Million )
  3. Asia-Pacific Insulin Delivery Market By Region, From 2016-2021 ( USD Million )
  4. Japan Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  5. China Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  6. India Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  7. Australia Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
  8. South Korea Diabetes Care Devices Market By Application, From 2016-2021 ( USD Million )
Middle-East And Africa Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Resea...
Latin America Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Insti...
Asia-Pacific Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Instit...
Europe Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Institutes, ...
North America Antibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Insti...
ANtibody Drug Conjugates Market By Pipeline Analysis (Phase, Mode Of Action [IgG1 Antibodies, HER2 Antibodies], Technology [Seattle Genetics, Immunogen, Immunomedics], Linker), End-user (Research Institutes, Hospita...
Middle-East And Africa Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity As...
Latin America Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tis...
Asia-Pacific Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tiss...
Europe Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Cu...
North America Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tis...
Early Toxicity Testing Market By Technique (In-vitro, In-vivo And In-Silico), Assays (Cell-Based ELISA And Western Blots, Enzyme Toxicity Assays, Receptor Binding Assays, Bacterial Toxicity Assays, Tissues Culture A...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.